According to CNBC, the digital pill it has developed with Otsuka, Abilify MyCite, has failed to gain traction. Otsuka has already invested $88 million in Proteus and has said it is committed to ...

Launched by Hong Kong-based Transsion Holdings, Itel Mobile claims its focus is on delivering cost-effective and high-specification mobile devices. Itel's latest mobile launch is the Pad One. The ...